bibliographic entry 6949469 [be/6949469]
https://w3id.org/oc/corpus/be/6949469

is a
content
  • Bosi E, Ellis GC, Wilson CA, Fleck PR. Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study. Diabetes Obes Metab 2011; 13:1088-96. doi:10.1111/j.1463-1326.2011.01463.x. 21733058.
references